ArticleBMJ public health2025
UK policymaker and expert perspectives on the smoke-free generation policy: a qualitative study.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The UK smoke-free generation (SFG) proposal seeks to ban the sale of tobacco products to those born in or after 2009. There is substantial evidence for the benefits of raising the age of sale of tobacco but, despite several governments proposing SFG, the policy has faced significant challenge and has not been implemented at nation-state level. This study explores the context in which UK may be the first country to introduce SFG, identifies potential barriers and facilitators to SFG implementation and outlines possible approaches to SFG policy design. Methods: We conducted 19 qualitative semistructured interviews with policymakers and health leaders in England, Scotland and Wales, including politicians, public health experts, academics, trading standards experts (responsible in UK for enforcing age restrictions on products), clinicians and civil society (charity sector) representatives. Data were analysed through Kingdon's three policy streams (problem, policy and political) and organised using the framework approach. Results: Participants conceptualised SFG as both addressing youth tobacco initiation and shifting societal norms. They agreed that all tobacco products should be included but had differing views on including e-cigarettes. Opinions on enforcement varied. Some believed minimal enforcement would suffice due to anticipated compliance, while others stressed the need for strong enforcement. All agreed enforcement should target retailers, not individuals. Politically, participants noted the rapid shift from advocates supporting Tobacco 21 to embracing SFG after government endorsement. Cohesive public health advocacy, maintaining cross-party support and public opinion and developing broader tobacco control policies were considerations for successful implementation. Conclusions: Widespread support for SFG across expert, political and public opinion provides a strong foundation for its passing into law. UK public health actors swiftly took advantage of the opening of a tobacco control policy window. Those implementing SFG must carefully consider product coverage and its approach to enforcement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.